Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent
2000
How glufosfamide works against cancer
publication
Author Information
Author(s): Seker H, Bertram B, Bürkle A, Kaina B, Pohl J, Koepsell H, Wießler M
Primary Institution: German Cancer Research Center, Heidelberg, Germany
Hypothesis
The study investigates the mode of action of glufosfamide at the DNA level.
Conclusion
Glufosfamide induces critical DNA crosslinks that lead to cytotoxicity in cancer cells.
Supporting Evidence
- Glufosfamide inhibited DNA and protein synthesis in a dose-dependent manner.
- Treatment with glufosfamide activated poly(ADP-ribose) polymerase in cancer cells.
- DNA crosslinks were identified as the most critical cytotoxic lesions induced by glufosfamide.
Takeaway
Glufosfamide is a new cancer treatment that damages DNA in cancer cells, making them unable to survive.
Methodology
The study used breast carcinoma cell lines and other cell types to assess the effects of glufosfamide on DNA and protein synthesis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website